Letter re: Impact of EDP-M on survival of patients with metastatic adrenocortical carcinoma: A population-based study

Affiliations

• ¹ Adrenal Cancer Unit, ASST-Spedali Civili, Brescia, Italy; Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, Medical Oncology Unit, University of Brescia at ASST-Spedali Civili, Brescia, Italy.
• ² Adrenal Cancer Unit, ASST-Spedali Civili, Brescia, Italy; Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, Medical Oncology Unit, University of Brescia at ASST-Spedali Civili, Brescia, Italy. Electronic address: deborah.cosentini@unibs.it.
• ³ Adrenal Cancer Unit, ASST-Spedali Civili, Brescia, Italy; Radiology Unit, ASST Spedali Civili, Brescia, Italy; Department of Clinical and Experimental Sciences, Surgical Unit, University of Brescia at ASST-Spedali Civili, Brescia, Italy.
• ⁴ Adrenal Cancer Unit, ASST-Spedali Civili, Brescia, Italy; Section of Pharmacology, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.